Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
3Customers
1Debt Items
8Related Chains
Source-Backed Evidence Depth
Passage Bio, Inc. (PASG) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
9Total relationships
2Distinct source URLs
6High confidence
0.784Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Passage Bio, Inc. Suppliers
Ticker
Name
Confidence
Evidence
GEMMA
GEMMA
90%
Pursuant to the Gemma Collaboration Agreement, (i) Gemma will conduct certain preclinical and Investigational New Drug, or IND, enabling work for the Company’s active research program in Huntington’s…
HOPEWELL-CAMPUS-OWNER-LLC
HOPEWELL-CAMPUS-OWNER-LLC
90%
Pursuant to the Hopewell Lease, the Company had leased approximately 62,000 square feet of laboratory space.
the Company is obligated to pay to Penn, on a licensed product-by-licensed product and country-by-country basis, tiered royalties (subject to customary reductions) in the mid-single digits percentage…
Reciprocal relationship from PENN graph: Reciprocal relationship from PASG graph: the Company is obligated to pay to Penn, on a licensed product-by-licensed product and country-by-country basis, tier…
Passage Bio, Inc. Customers
Ticker
Name
Confidence
Evidence
COMPANY-LLC
COMPANY-LLC
62%
e successful development and eventual commercialization of one or more of our current or future product candidates. We expect to continue to incur significant expenses and operating losses for the fo…
GEMMA-BIOTHERAPEUTICS-INC
GEMMA-BIOTHERAPEUTICS-INC
62%
or changes indicate the carrying amount of the ROU assets may not be recoverable. The Company did no t recognize any impairment expenses for ROU assets for the three months ended March 31, 2026 or 20…
NOVO-HOLDINGS
NOVO-HOLDINGS
62%
Sublease Agreement B On September 29, 2023, the Company entered into a sublease agreement with a counterparty, or Sublessee B, to sublease approximately 29,000 square feet of the 2005 Market Street…
Passage Bio, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
PASG-DEBT
Debt stack $5.8M
90%
Market cache reports total debt of $5.8M.
Passage Bio, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Passage Bio, Inc..
Passage Bio, Inc. Ownership
Holder
Name
Confidence
Evidence
PASG-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 1 tracked holders.
